Search
Nyxoah SA
NYXHAdd to Watchlist
1.400USD
-0.010-0.71%
Close 07-31 16:00（ET）Quotes delayed by 15 min
60.24MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Nyxoah SA is 8.40, ranking 41 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 12.00, with a high of 15.00 and a low of 9.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
8.500
Target Price
+511.51%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Nyxoah SA
NYXH
5
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Nyxoah SA's expected revenue for the next quarter?
Nyxoah SA's expected revenue is 8.83M.
What is Nyxoah SA's price target?
Analysts forecast that Nyxoah SA's price target is USD 12.00, with the highest forecast at USD 15.00 and the lowest forecast at USD 9.00.
How have Nyxoah SANYXH's recent earnings per share performed?
The market expectation was USD -0.43, while Nyxoah SANYXH's earnings per share (EPS) for the previous quarter was USD -0.69. EPS for the next quarter is expected at USD -0.48.
What is the analyst rating for Nyxoah SA?
Based on the ratings of Nyxoah SA's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.